Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1781-1790 of 2905 for cancer

Edit search filters
  1. Stereotactic Body Radiation Therapy With Immunotherapy For The Treatment Of Mesothelioma

    Rochester, MN

  2. Investigating Magnesium Glycinate In Structure/Function Role Of Hot Flashes.

    Jacksonville, FL

  3. A Study Comparing Orteronel Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer, Who Have Not Had Chemotherapy

    Jacksonville, FL, Rochester, MN

  4. A Study Of Cabiralizumab Given With Nivolumab With And Without Chemotherapy In Patients With Advanced Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  5. Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With Or Without Bevacizumab In Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ

  6. Once-daily Oral VT-464 In Patients With Castration-Resistant Prostate Cancer Progressing On Enzalutamide Or Abiraterone.

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Ribociclib And Letrozole In Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, Or Endometrial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. PD 0332991 And Anastrozole For Stage 2 Or 3 Estrogen Receptor Positive And HER2 Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study To Evaluate The Safety And Immunological Effect Of Pembrolizumab In Resectable Or Borderline Resectable Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  10. Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer

    Rochester, MN

.

Mayo Clinic Footer